Home / Companies / Mirum Pharmaceuticals, Inc. / 29 May 2025
Mirum Pharmaceuticals, Inc.: meeting of 29 May 2025
Votes reported on Form N-PX, item by item
344 Form N-PX filers reported votes at the Mirum Pharmaceuticals, Inc. meeting of 29 May 2025. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
3 nominees; 71.8% of reported votes for; 80 filers withheld from or voted against at least one nominee.
640 vote records from 125 filers. 20 of the 124 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
482 vote records from 340 filers. 21 of the 329 filers that marked the item either way voted against management. 11 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
214 vote records from 125 filers. 1 of the 124 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | Abstain or withhold * | For | For |
| Fidelity | For | For | For |
| Dimensional | No report | For | No report |
| State Street and SPDR | Abstain or withhold * | For | For |
| Franklin Templeton | For | For | For |
| Invesco | For | For | For |
| Equitable | Abstain or withhold * | For | For |
| Charles Schwab | For | For | For |
| Nuveen and TIAA | For | For | For |
| ProShares and ProFunds | For | For | For |
| John Hancock and Manulife | For | For | For |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | For | For |
| J.P. Morgan | For | For | For |
| Goldman Sachs | For | For | For |
| WisdomTree | For | For | For |
| PGIM and Prudential | No report | For | No report |
| Northern Trust and FlexShares | For | For | For |
| SEI | For | For | For |
| T. Rowe Price | For | For | For |
| Lincoln Financial | For | For | For |
| Voya | Abstain or withhold * | For | For |
| First Trust | For | For | For |
| Russell Investments | For | For | For |
| Nationwide | Abstain or withhold * | For | For |
| Victory Capital | For | For | For |
| Brighthouse Funds | For | For | For |
| Guggenheim and Rydex | For | For | For |
| Columbia Threadneedle | For | Against * | For |
| BNY Mellon | For | Against * | For |
| Principal | For | For | For |
| Pacific Life funds | Abstain or withhold * | For | For |
| Global X | For | For | For |
| Transamerica | For | For | For |
| Federated Hermes | For | For | For |
| AllianceBernstein | No report | For | No report |
| DWS | For | For | For |
| PIMCO | No report | For | No report |
| Allspring | No report | For | No report |
| MassMutual | For | For | For |
| Virtus | For | For | For |
| Macquarie and Delaware Funds | Abstain or withhold * | For | For |
| Janus Henderson | For | For | For |
| Neuberger Berman | No report | For | No report |
| Natixis and Loomis Sayles | For | For | For |
| Lord Abbett | For | For | For |
| Baird | No report | For | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Mirum Pharmaceuticals, Inc. meeting?
344 Form N-PX filers reported votes at the meeting of 29 May 2025. On say-on-pay, 21 of 329 voted against management (6.4%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Mirum Pharmaceuticals, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Mirum Pharmaceuticals, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Mirum Pharmaceuticals, Inc. with a meeting date within three days of 29 May 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.